Drugs / MTA
last change Oct 2017 re-read 2 minutes ago

MTA

Developed for
isolated congenital femoral bifurcation

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT02805101 Comparator Jan 2015 → Jun 2017 isolated congenital femoral bifurcation Damascus University Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MTA ClinicalTrials.gov intervention name — accepted as the source's own label NCT02805101